After lonely labwork and distancing during the pandemic winter, we are looking forward to spring and freely shared and fun immunology. From left: Taissa, Hanne, Elias, and Kjell-Rune.
Kick-Off Fall 2019
We are saving the world one Escape room at the time. Here, we prevented a massive bioterror attack to be launched from Oslo in just 47 minutes.
Tjärnhage E, Våtsveen TK, Raki M, Nemazee D, Farhan H, Munthe L, Grodeland G(2026) Repurposing ALK inhibitors as influenza and corona virus antivirals targeting lymphocyte tyrosine kinase (LTK) Virus Res, 370, 199759 DOI 10.1016/j.virusres.2026.199759, PubMed 42263913
Anderson AM, Tjärnhage E, Hinke DM, Braathen R, Grodeland G, Bogen B(2025) DNA vaccines targeting hemagglutinin from 18 subtypes of influenza A virus to antigen-presenting cells confer broad protection Mol Ther Nucleic Acids, 37(1), 102814 DOI 10.1016/j.omtn.2025.102814, PubMed 41568167
de Jong R, Zhou F, Andersen TK, Stockhofe-Zurwieden N, Cox RJ, Bogen B, Grodeland G(2025) An HLAII-targeted DNA vaccine against influenza H7N9 protected mice and ferrets from a virus challenge NPJ Vaccines, 11(1), 20 DOI 10.1038/s41541-025-01341-4, PubMed 41444253
